ArticleJournal of imaging2026
MSWA-ResNet: Multi-Scale Wavelet Attention for Patient-Level and Interpretable Breast Cancer Histopathology Classification.
Article in Journal of imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer histopathological classification is critical for diagnosis and treatment planning, yet manual assessment remains time-consuming and subject to inter-observer variability. Although deep learning approaches have advanced automated analysis, image-level data splitting may introduce data leakage, and spatial-domain architectures lack explicit multi-scale frequency modeling. This study proposes MSWA-ResNet, a Multi-Scale Wavelet Attention Residual Network that embeds recursive discrete wavelet decomposition within residual blocks to enable frequency-aware and scale-aware feature learning. The model is evaluated on the BreakHis dataset using a strict patient-level protocol with 70/30 patient-wise splitting, five-fold stratified cross-validation, ensemble prediction, and hierarchical aggregation from patch to patient level. MSWA-ResNet achieves 96% patient-level accuracy at 100×, 200×, and 400× magnifications, and 92% at 40×, with F1-scores of 0.97 and 0.94, respectively. At 200× and 400×, accuracy improves from 0.92 to 0.96 and F1-score from 0.94 to 0.97 over baseline CNNs while maintaining 11.8-12.1 M parameters and 2.5-4.8 ms inference time. Grad-CAM demonstrates improved localization of diagnostically relevant regions, indicating that explicit multi-scale frequency modeling enhances accurate and interpretable patient-level classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.